Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection - ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
Britain gave AstraZeneca's COVID-19 vaccine a vote of confidence on Friday when it asked its regulator to assess it for a rollout after experts raised questions about trial data and the company said it may run another study to gauge the shot's efficacy.
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, its chief executive Pascal Soriot was quoted as saying on Thursday after questions over the results from its late-stage study.
Countries around the world are scrambling to finalise vaccine deals as the global number of coronavirus infections approached 60 million on Wednesday, scientists urged caution and U.S. officials pleaded with Americans to stay home over Thanksgiving.
The European Union has reached a deal with U.S. biotech firm Moderna for the supply of its COVID-19 vaccine candidate, the head of the European Commission...
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday.
France is expected to loosen its coronavirus restrictions on Tuesday as the boss of a major airline said proof of vaccination will likely become the only way...
AstraZeneca will have enough of its candidate vaccine for 200 million doses by the end of 2020, with drug substance for 700 million doses by the end of the...
Somali-American model Halima Aden has announced that she is taking a step back from the fashion industry, saying the pandemic slowdown has allowed her to see...
On a darkened residential street in Paris, a gate left partly open signals the entrance to an abandoned train tunnel -- and an illegal rave party for 300...
The state of Lebanon’s wine industry has previously been assessed to be in dire straits thanks to the current depth of crises facing the country.
A rocket heading for the moon to bring back the first lunar samples in four decades blasted off from China on Tuesday in the latest milestone for Beijing's...
Twitter Inc and Facebook Inc will transfer control of the @POTUS account to the Joe Biden administration on Jan. 20, the social media companies said on...
Italy is to offer Europe's first coronavirus-free corridor with the United States for passengers who have tested negative for Covid-19, scrapping the...
Boeing Co reported its fourth straight quarterly loss Wednesday as the coronavirus pandemic and 737 MAX grounding continued to hammer sales, while reaffirming...
Mazda beat traditional winners Lexus and Toyota to win top honors as the most dependable auto brand in Consumer Reports' annual reliability survey.
Honda on Wednesday won approval to sell Level 3 autonomous cars in Japan, in what the automaker and Japanese authorities said was a world-first.
Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of...
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to...
The first Americans could receive a COVID-19 vaccine as soon as Dec. 11, the chief scientific adviser for the U.S. government's vaccine program said on Sunday.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first...
AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with...
Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required...
The United States' top infectious disease scientist on Monday hailed early trial results from Moderna's Covid-19 vaccine as "stunningly impressive," and said...
Moderna Inc said Monday its experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial,...
Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies...
US government scientist Anthony Fauci said Thursday the coronavirus vaccine "cavalry" is coming but urged the public not to let down its guard, and called for...
So why did I volunteer to be injected with an experimental vaccine for COVID-19? That's what some of my friends wanted to know when I told them what I was...
Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on...
The United States on Tuesday registered a record 200,000 new Covid-19 cases in one day, highlighting the desperate need for a vaccine after results from one...
Many COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20 percent of...
Brazil's health regulator has suspended a clinical trial for China's Sinovac coronavirus vaccine citing a severe adverse event, surprising the trial...
BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below "typical market rates" and...
The European Union will soon sign a contract for millions of doses of the COVID-19 vaccine being developed by Pfizer and BioNTech, the head of the European...
Russia's Sputnik V vaccine against COVID-19 is more than 90 percent effective, a representative of the health ministry said Monday, citing data collated from...
A COVID-19 vaccine may be rolled out by March 2021 to the most vulnerable, which along with other advances could fundamentally change the course of the...
Britain expects to have 10 million doses of Pfizer/BioNTech's candidate COVID-19 vaccine available by the end of the year if regulators approve it, Prime...
A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies...